| UniProt ID | MYCN_HUMAN | |
|---|---|---|
| UniProt AC | P04198 | |
| Protein Name | N-myc proto-oncogene protein | |
| Gene Name | MYCN | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 464 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Positively regulates the transcription of MYCNOS in neuroblastoma cells.. | |
| Protein Sequence | MPSCSTSTMPGMICKNPDLEFDSLQPCFYPDEDDFYFGGPDSTPPGEDIWKKFELLPTPPLSPSRGFAEHSSEPPSWVTEMLLENELWGSPAEEDAFGLGGLGGLTPNPVILQDCMWSGFSAREKLERAVSEKLQHGRGPPTAGSTAQSPGAGAASPAGRGHGGAAGAGRAGAALPAELAHPAAECVDPAVVFPFPVNKREPAPVPAAPASAPAAGPAVASGAGIAAPAGAPGVAPPRPGGRQTSGGDHKALSTSGEDTLSDSDDEDDEEEDEEEEIDVVTVEKRRSSSNTKAVTTFTITVRPKNAALGPGRAQSSELILKRCLPIHQQHNYAAPSPYVESEDAPPQKKIKSEASPRPLKSVIPPKAKSLSPRNSDSEDSERRRNHNILERQRRNDLRSSFLTLRDHVPELVKNEKAAKVVILKKATEYVHSLQAEEHQLLLEKEKLQARQQQLLKKIEHARTC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MPSCSTSTMP -----CCCCCCCCCC | 21.28 | 18669648 | |
| 5 | Phosphorylation | ---MPSCSTSTMPGM ---CCCCCCCCCCCC | 29.72 | 18669648 | |
| 6 | Phosphorylation | --MPSCSTSTMPGMI --CCCCCCCCCCCCC | 32.32 | 18669648 | |
| 7 | Phosphorylation | -MPSCSTSTMPGMIC -CCCCCCCCCCCCCC | 13.35 | 18669648 | |
| 8 | Phosphorylation | MPSCSTSTMPGMICK CCCCCCCCCCCCCCC | 27.72 | 18669648 | |
| 52 | Ubiquitination | PGEDIWKKFELLPTP CCHHHHHHHCCCCCC | 29.13 | - | |
| 58 | Phosphorylation | KKFELLPTPPLSPSR HHHCCCCCCCCCCCC | 37.19 | 29255136 | |
| 62 | Phosphorylation | LLPTPPLSPSRGFAE CCCCCCCCCCCCCCC | 26.97 | 29255136 | |
| 64 | Phosphorylation | PTPPLSPSRGFAEHS CCCCCCCCCCCCCCC | 41.48 | 29255136 | |
| 65 | Methylation | TPPLSPSRGFAEHSS CCCCCCCCCCCCCCC | 47.86 | 118350215 | |
| 133 | Acetylation | LERAVSEKLQHGRGP HHHHHHHHHHCCCCC | 46.04 | 23749302 | |
| 142 | Phosphorylation | QHGRGPPTAGSTAQS HCCCCCCCCCCCCCC | 46.94 | 27732954 | |
| 145 | Phosphorylation | RGPPTAGSTAQSPGA CCCCCCCCCCCCCCC | 20.36 | 27732954 | |
| 146 | Phosphorylation | GPPTAGSTAQSPGAG CCCCCCCCCCCCCCC | 28.00 | 27732954 | |
| 149 | Phosphorylation | TAGSTAQSPGAGAAS CCCCCCCCCCCCCCC | 23.88 | 27732954 | |
| 156 | Phosphorylation | SPGAGAASPAGRGHG CCCCCCCCCCCCCCC | 18.10 | 27732954 | |
| 238 | Methylation | APGVAPPRPGGRQTS CCCCCCCCCCCCCCC | 41.24 | 422795205 | |
| 242 | Methylation | APPRPGGRQTSGGDH CCCCCCCCCCCCCCC | 42.38 | 422795199 | |
| 253 | Phosphorylation | GGDHKALSTSGEDTL CCCCCCCCCCCCCCC | 25.95 | 30177828 | |
| 254 | Phosphorylation | GDHKALSTSGEDTLS CCCCCCCCCCCCCCC | 41.42 | 30177828 | |
| 255 | Phosphorylation | DHKALSTSGEDTLSD CCCCCCCCCCCCCCC | 36.49 | 30177828 | |
| 259 | Phosphorylation | LSTSGEDTLSDSDDE CCCCCCCCCCCCCCC | 24.70 | 30177828 | |
| 261 | Phosphorylation | TSGEDTLSDSDDEDD CCCCCCCCCCCCCCC | 36.84 | 22817900 | |
| 263 | Phosphorylation | GEDTLSDSDDEDDEE CCCCCCCCCCCCCCC | 43.52 | 15821734 | |
| 287 | Phosphorylation | VTVEKRRSSSNTKAV EEEEEECCCCCCCEE | 42.00 | 28270605 | |
| 288 | Phosphorylation | TVEKRRSSSNTKAVT EEEEECCCCCCCEEE | 26.29 | 28152594 | |
| 289 | Phosphorylation | VEKRRSSSNTKAVTT EEEECCCCCCCEEEE | 50.17 | 28152594 | |
| 291 | Phosphorylation | KRRSSSNTKAVTTFT EECCCCCCCEEEEEE | 23.48 | 28152594 | |
| 295 | Phosphorylation | SSNTKAVTTFTITVR CCCCCEEEEEEEEEC | 22.50 | 28270605 | |
| 296 | Phosphorylation | SNTKAVTTFTITVRP CCCCEEEEEEEEECC | 16.51 | 28270605 | |
| 298 | Phosphorylation | TKAVTTFTITVRPKN CCEEEEEEEEECCCC | 17.41 | 28270605 | |
| 300 | Phosphorylation | AVTTFTITVRPKNAA EEEEEEEEECCCCCC | 13.86 | 28270605 | |
| 315 | Phosphorylation | LGPGRAQSSELILKR CCCCCCCCHHHHHHH | 25.46 | 27732954 | |
| 316 | Phosphorylation | GPGRAQSSELILKRC CCCCCCCHHHHHHHH | 25.09 | 27732954 | |
| 321 | Ubiquitination | QSSELILKRCLPIHQ CCHHHHHHHHCHHHH | 33.79 | - | |
| 352 | O-linked_Glycosylation | PPQKKIKSEASPRPL CCCHHCCCCCCCCCC | 41.70 | 30379171 | |
| 355 | Phosphorylation | KKIKSEASPRPLKSV HHCCCCCCCCCCHHC | 19.86 | 24667141 | |
| 361 | Phosphorylation | ASPRPLKSVIPPKAK CCCCCCHHCCCCCCC | 32.72 | 28060719 | |
| 369 | Phosphorylation | VIPPKAKSLSPRNSD CCCCCCCCCCCCCCC | 38.65 | 24719451 | |
| 371 | Phosphorylation | PPKAKSLSPRNSDSE CCCCCCCCCCCCCCH | 28.98 | 24719451 | |
| 375 | Phosphorylation | KSLSPRNSDSEDSER CCCCCCCCCCHHHHH | 43.74 | 30177828 | |
| 377 | Phosphorylation | LSPRNSDSEDSERRR CCCCCCCCHHHHHHH | 43.02 | 30177828 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 58 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
| 62 | S | Phosphorylation | Kinase | MTOR | P42345 | PSP |
| 261 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
| 261 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
| 261 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
| 261 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
| 263 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
| 263 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
| 263 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
| 263 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
| - | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:23175188 |
| - | K | Ubiquitination | E3 ubiquitin ligase | TRIM32 | Q13049 | PMID:25100564 |
| - | K | Ubiquitination | E3 ubiquitin ligase | HUWE1 | Q7Z6Z7 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | FBXW7 | Q969H0 | PMID:19111882 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MYCN_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MYCN_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MAX_HUMAN | MAX | physical | 2006410 | |
| FBXW7_HUMAN | FBXW7 | physical | 19111882 | |
| SP1_HUMAN | SP1 | physical | 21123453 | |
| SIR1_HUMAN | SIRT1 | physical | 21698133 | |
| ZBT17_HUMAN | ZBTB17 | physical | 21908575 | |
| CDN2A_HUMAN | CDKN2A | physical | 17289033 | |
| ARF_HUMAN | CDKN2A | physical | 17289033 | |
| MAX_HUMAN | MAX | physical | 17289033 | |
| NMI_HUMAN | NMI | physical | 10597290 | |
| HDAC5_HUMAN | HDAC5 | physical | 23812427 | |
| TRI32_HUMAN | TRIM32 | physical | 25100564 | |
| NEDD4_HUMAN | NEDD4 | physical | 23175188 | |
| ZBT17_HUMAN | ZBTB17 | physical | 21123453 | |
| WDR5_HUMAN | WDR5 | physical | 26471359 | |
| HUWE1_HUMAN | HUWE1 | physical | 18488021 | |
| LPPRC_HUMAN | LRPPRC | physical | 18488021 | |
| MAX_HUMAN | MAX | physical | 18488021 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| Note=Amplification of the N-MYC gene is associated with a variety of human tumors, most frequently neuroblastoma, where the level of amplification appears to increase as the tumor progresses. | ||||||
| 164280 | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-58 AND SER-62, AND MASSSPECTROMETRY. | |